- Home
- CLS vs IQV Comparison
CLS vs IQV Comparison
Compare CLS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLS
- IQV
- Stock Information
- Founded
- CLS 1994
- IQV 1982
- Country
- CLS Canada
- IQV United States
- Employees
- CLS N/A
- IQV N/A
- Industry
- CLS Electrical Products
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CLS Technology
- IQV Health Care
- Exchange
- CLS Nasdaq
- IQV Nasdaq
- Market Cap
- CLS 31.1B
- IQV 37.2B
- IPO Year
- CLS 1998
- IQV 2013
- Fundamental
- Price
- CLS $344.48
- IQV $216.46
- Analyst Decision
- CLS Buy
- IQV Strong Buy
- Analyst Count
- CLS 13
- IQV 20
- Target Price
- CLS $296.08
- IQV $242.10
- AVG Volume (30 Days)
- CLS 3.2M
- IQV 1.7M
- Earning Date
- CLS 10-27-2025
- IQV 10-28-2025
- Dividend Yield
- CLS N/A
- IQV N/A
- EPS Growth
- CLS 103.66
- IQV N/A
- EPS
- CLS 6.15
- IQV 7.30
- Revenue
- CLS $11,281,700,000.00
- IQV $15,904,000,000.00
- Revenue This Year
- CLS $20.66
- IQV $6.01
- Revenue Next Year
- CLS $19.38
- IQV $4.87
- P/E Ratio
- CLS $55.31
- IQV $29.64
- Revenue Growth
- CLS 22.09
- IQV 3.85
- 52 Week Low
- CLS $58.05
- IQV $134.65
- 52 Week High
- CLS $360.99
- IQV $225.91
- Technical
- Relative Strength Index (RSI)
- CLS 77.98
- IQV 63.90
- Support Level
- CLS $329.24
- IQV $209.46
- Resistance Level
- CLS $355.50
- IQV $222.59
- Average True Range (ATR)
- CLS 18.79
- IQV 5.99
- MACD
- CLS 7.05
- IQV -0.12
- Stochastic Oscillator
- CLS 86.55
- IQV 65.80
About CLS Celestica Inc.
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.